{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T01:08:22Z","timestamp":1779066502683,"version":"3.51.4"},"publisher-location":"Cham","reference-count":162,"publisher":"Springer Nature Switzerland","isbn-type":[{"value":"9783032218605","type":"print"},{"value":"9783032218612","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-3-032-21861-2_7","type":"book-chapter","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:42:22Z","timestamp":1779064942000},"page":"121-154","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metabolic Cross Talk in the Tumor Microenvironment"],"prefix":"10.1007","author":[{"given":"Chinmay","family":"Das","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Somya Ranjan","family":"Dash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biswajit","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subhajit","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4547-079X","authenticated-orcid":false,"given":"Tithi","family":"Parija","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,1]]},"reference":[{"key":"7_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217385","volume":"611","author":"H Yu","year":"2025","unstructured":"Yu H, Li J, Peng S, et al. Tumor microenvironment: nurturing cancer cells for immunoevasion and druggable vulnerabilities for cancer immunotherapy. Cancer Lett. 2025;611:217385.","journal-title":"Cancer Lett"},{"key":"7_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-020-0530-4","volume":"18","author":"R Baghban","year":"2020","unstructured":"Baghban R, Roshangar L, Jahanban-Esfahlan R, et al. Tumor microenvironment complexity and therapeutic implications at a glance. Cell Commun Signal. 2020;18:59. https:\/\/doi.org\/10.1186\/s12964-020-0530-4.","journal-title":"Cell Commun Signal"},{"key":"7_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/6283796","volume":"2020","author":"R Wei","year":"2020","unstructured":"Wei R, Liu S, Zhang S, et al. Cellular and extracellular components in tumor microenvironment and their application in early diagnosis of cancers. Anal Cell Pathol. 2020;2020:1\u201313. https:\/\/doi.org\/10.1155\/2020\/6283796.","journal-title":"Anal Cell Pathol"},{"key":"7_CR4","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41568-021-00378-6","volume":"21","author":"I Mart\u00ednez-Reyes","year":"2021","unstructured":"Mart\u00ednez-Reyes I, Chandel NS. Cancer metabolism: looking forward. Nat Rev Cancer. 2021;21:669\u201380.","journal-title":"Nat Rev Cancer"},{"key":"7_CR5","doi-asserted-by":"publisher","first-page":"3898","DOI":"10.3390\/cancers15153898","volume":"15","author":"S Cortellino","year":"2023","unstructured":"Cortellino S, Longo VD. Metabolites and immune response in tumor microenvironments. Cancer. 2023;15:3898.","journal-title":"Cancer"},{"key":"7_CR6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s42255-020-00317-z","volume":"3","author":"I Elia","year":"2021","unstructured":"Elia I, Haigis MC. Metabolites and the tumour microenvironment: from cellular mechanisms to systemic metabolism. Nat Metab. 2021;3:21\u201332.","journal-title":"Nat Metab"},{"key":"7_CR7","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40164-024-00482-x","volume":"13","author":"J Yang","year":"2024","unstructured":"Yang J, Shay C, Saba NF, Teng Y. Cancer metabolism and carcinogenesis. Exp Hematol Oncol. 2024;13:10. https:\/\/doi.org\/10.1186\/s40164-024-00482-x.","journal-title":"Exp Hematol Oncol"},{"key":"7_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.868695","volume":"13","author":"SK Kim","year":"2022","unstructured":"Kim SK, Cho SW. The evasion mechanisms of cancer immunity and drug intervention in the tumor microenvironment. Front Pharmacol. 2022;13:868695.","journal-title":"Front Pharmacol"},{"key":"7_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-024-01600-2","volume":"17","author":"F Zhang","year":"2024","unstructured":"Zhang F, Ma Y, Li D, et al. Cancer associated fibroblasts and metabolic reprogramming: unraveling the intricate crosstalk in tumor evolution. J Hematol Oncol. 2024;17:80. https:\/\/doi.org\/10.1186\/s13045-024-01600-2.","journal-title":"J Hematol Oncol"},{"key":"7_CR10","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.freeradbiomed.2016.04.025","volume":"100","author":"M Sciacovelli","year":"2016","unstructured":"Sciacovelli M, Frezza C. Oncometabolites: unconventional triggers of oncogenic signalling cascades. Free Radic Biol Med. 2016;100:175\u201381.","journal-title":"Free Radic Biol Med"},{"key":"7_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/biology11020270","volume":"11","author":"M Bary\u0142a","year":"2022","unstructured":"Bary\u0142a M, Semeniuk-Wojta\u015b A, R\u00f3g L, et al. Oncometabolites\u2014a link between cancer cells and tumor microenvironment. Biology. 2022;11:270.","journal-title":"Biology"},{"key":"7_CR12","doi-asserted-by":"publisher","first-page":"8815","DOI":"10.1038\/s41598-017-09307-w","volume":"7","author":"JX Zhou","year":"2017","unstructured":"Zhou JX, Taramelli R, Pedrini E, et al. Extracting intercellular signaling network of cancer tissues using ligand-receptor expression patterns from whole-tumor and single-cell transcriptomes. Sci Rep. 2017;7:8815.","journal-title":"Sci Rep"},{"key":"7_CR13","doi-asserted-by":"publisher","first-page":"115432","DOI":"10.1016\/j.celrep.2025.115432","volume":"44","author":"EJ Kay","year":"2025","unstructured":"Kay EJ, Zanivan S. The tumor microenvironment is an ecosystem sustained by metabolic interactions. Cell Rep. 2025;44:115432.","journal-title":"Cell Rep"},{"key":"7_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216396","volume":"575","author":"Z Luo","year":"2023","unstructured":"Luo Z, Eichinger KM, Zhang A, Li S. Targeting cancer metabolic pathways for improving chemotherapy and immunotherapy. Cancer Lett. 2023;575:216396.","journal-title":"Cancer Lett"},{"key":"7_CR15","doi-asserted-by":"publisher","first-page":"6028","DOI":"10.3390\/cancers14246028","volume":"14","author":"E Kocianova","year":"2022","unstructured":"Kocianova E, Piatrikova V, Golias T. Revisiting the Warburg effect with focus on lactate. Cancer. 2022;14:6028.","journal-title":"Cancer"},{"key":"7_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/3119375","volume":"2022","author":"Y Gao","year":"2022","unstructured":"Gao Y, Zhou H, Liu G, et al. Tumor microenvironment: lactic acid promotes tumor development. J Immunol Res. 2022;2022:1\u20138. https:\/\/doi.org\/10.1155\/2022\/3119375.","journal-title":"J Immunol Res"},{"key":"7_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2023.1113739","volume":"10","author":"Z Li","year":"2023","unstructured":"Li Z, Wang Q, Huang X, et al. Lactate in the tumor microenvironment: a rising star for targeted tumor therapy. Front Nutr. 2023;10:1113739.","journal-title":"Front Nutr"},{"key":"7_CR18","doi-asserted-by":"publisher","first-page":"6261","DOI":"10.1038\/s41598-022-10143-w","volume":"12","author":"S Ishihara","year":"2022","unstructured":"Ishihara S, Hata K, Hirose K, et al. The lactate sensor GPR81 regulates glycolysis and tumor growth of breast cancer. Sci Rep. 2022;12:6261.","journal-title":"Sci Rep"},{"key":"7_CR19","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/s41523-021-00324-7","volume":"7","author":"J Gyamfi","year":"2021","unstructured":"Gyamfi J, Yeo JH, Kwon D, et al. Interaction between CD36 and FABP4 modulates adipocyte-induced fatty acid import and metabolism in breast cancer. NPJ Breast Cancer. 2021;7:129.","journal-title":"NPJ Breast Cancer"},{"key":"7_CR20","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/CAD.0000000000000971","volume":"32","author":"Z Cui","year":"2021","unstructured":"Cui Z, Liu J, Sun Q, et al. GPR120 promotes radiation resistance in esophageal cancer via regulating AKT and apoptosis pathway. Anti-Cancer Drugs. 2021;32:53\u201360.","journal-title":"Anti-Cancer Drugs"},{"key":"7_CR21","doi-asserted-by":"publisher","first-page":"1079076","DOI":"10.3389\/fcell.2022.1079076","volume":"10","author":"SL Guerrero-Rodriguez","year":"2022","unstructured":"Guerrero-Rodriguez SL, Mata-Cruz C, Perez-Tapia SM, Velasco-Velazquez MA. Role of CD36 in cancer progression, stemness, and targeting. Front Cell Dev Biol. 2022;10:1079076.","journal-title":"Front Cell Dev Biol"},{"key":"7_CR22","doi-asserted-by":"publisher","first-page":"5","DOI":"10.21037\/tbcr-20-53","volume":"2","author":"J Zhao","year":"2021","unstructured":"Zhao J, Xie F, Yang Y, Wang S. Reprogramming of fatty acid metabolism in breast cancer: a narrative review. Transl Breast Cancer Res. 2021;2:5.","journal-title":"Transl Breast Cancer Res"},{"key":"7_CR23","doi-asserted-by":"publisher","first-page":"G341","DOI":"10.1152\/ajpgi.00163.2022","volume":"324","author":"A Griffiths","year":"2023","unstructured":"Griffiths A, Wang J, Song Q, et al. ATF4-mediated CD36 upregulation contributes to palmitate-induced lipotoxicity in hepatocytes. Am J Physiol-Gastrointest Liver Physiol. 2023;324:G341\u201353. https:\/\/doi.org\/10.1152\/ajpgi.00163.2022.","journal-title":"Am J Physiol-Gastrointest Liver Physiol"},{"key":"7_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/cells11223556","volume":"11","author":"NE Zaidi","year":"2022","unstructured":"Zaidi NE, Shazali NAH, Leow T-C, et al. CD36-fatty acid-mediated metastasis via the bidirectional interactions of cancer cells and macrophages. Cells. 2022;11:3556.","journal-title":"Cells"},{"key":"7_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.858462","volume":"12","author":"N Jyotsana","year":"2022","unstructured":"Jyotsana N, Ta KT, DelGiorno KE. The role of cystine\/glutamate antiporter SLC7A11\/xCT in the pathophysiology of cancer. Front Oncol. 2022;12:858462.","journal-title":"Front Oncol"},{"key":"7_CR26","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3390\/cancers13020203","volume":"13","author":"C Lopes","year":"2021","unstructured":"Lopes C, Pereira C, Medeiros R. ASCT2 and LAT1 contribution to the hallmarks of cancer: from a molecular perspective to clinical translation. Cancer. 2021;13:203.","journal-title":"Cancer"},{"key":"7_CR27","doi-asserted-by":"publisher","first-page":"2958","DOI":"10.1111\/cas.15006","volume":"112","author":"Y Saito","year":"2021","unstructured":"Saito Y, Soga T. Amino acid transporters as emerging therapeutic targets in cancer. Cancer Sci. 2021;112:2958\u201365. https:\/\/doi.org\/10.1111\/cas.15006.","journal-title":"Cancer Sci"},{"key":"7_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.963066","volume":"13","author":"G Gauthier-Coles","year":"2022","unstructured":"Gauthier-Coles G, Br\u00f6er A, McLeod MD, et al. Identification and characterization of a novel SNAT2 (SLC38A2) inhibitor reveals synergy with glucose transport inhibition in cancer cells. Front Pharmacol. 2022;13:963066.","journal-title":"Front Pharmacol"},{"key":"7_CR29","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/s41419-024-06435-w","volume":"15","author":"J Chen","year":"2024","unstructured":"Chen J, Cui L, Lu S, Xu S. Amino acid metabolism in tumor biology and therapy. Cell Death Dis. 2024;15:42.","journal-title":"Cell Death Dis"},{"key":"7_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.359","volume":"4","author":"Y Ai","year":"2023","unstructured":"Ai Y, Wang H, Liu L, et al. Purine and purinergic receptors in health and disease. MedComm. 2023;4:e359. https:\/\/doi.org\/10.1002\/mco2.359.","journal-title":"MedComm"},{"key":"7_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1455469","volume":"15","author":"CFF Gardani","year":"2024","unstructured":"Gardani CFF, Diz FM, Dond\u00e9 LB, et al. The potential role of purinergic signaling in cancer therapy: perspectives on anti-CD73 strategies for prostate cancer. Front Immunol. 2024;15:1455469.","journal-title":"Front Immunol"},{"key":"7_CR32","doi-asserted-by":"publisher","first-page":"5649","DOI":"10.21037\/tcr-24-679","volume":"13","author":"R Qu","year":"2024","unstructured":"Qu R, Zhao Y, Zhang Y. The mechanism of cytokine regulation of cancer occurrence and development in the tumor microenvironment and its application in cancer treatment: a narrative review. Transl Cancer Res. 2024;13:5649.","journal-title":"Transl Cancer Res"},{"key":"7_CR33","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41392-024-01868-3","volume":"9","author":"M Yi","year":"2024","unstructured":"Yi M, Li T, Niu M, et al. Targeting cytokine and chemokine signaling pathways for cancer therapy. Signal Transduct Target Ther. 2024;9:176.","journal-title":"Signal Transduct Target Ther"},{"key":"7_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.446","volume":"4","author":"N Zhang","year":"2023","unstructured":"Zhang N, Li Y. Receptor tyrosine kinases: biological functions and anticancer targeted therapy. MedComm. 2023;4:e446. https:\/\/doi.org\/10.1002\/mco2.446.","journal-title":"MedComm"},{"key":"7_CR35","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/j.cell.2015.08.016","volume":"162","author":"C-H Chang","year":"2015","unstructured":"Chang C-H, Qiu J, O\u2019Sullivan D, et al. Metabolic competition in the tumor microenvironment is a driver of cancer progression. Cell. 2015;162:1229\u201341. https:\/\/doi.org\/10.1016\/j.cell.2015.08.016.","journal-title":"Cell"},{"key":"7_CR36","doi-asserted-by":"publisher","first-page":"3812","DOI":"10.1182\/blood-2006-07-035972","volume":"109","author":"K Fischer","year":"2007","unstructured":"Fischer K, Hoffmann P, Voelkl S, et al. Inhibitory effect of tumor cell\u2013derived lactic acid on human T cells. Blood. 2007;109:3812\u20139. https:\/\/doi.org\/10.1182\/blood-2006-07-035972.","journal-title":"Blood"},{"key":"7_CR37","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1158\/0008-5472.CAN-15-1743","volume":"76","author":"S Pilon-Thomas","year":"2016","unstructured":"Pilon-Thomas S, Kodumudi KN, El-Kenawi AE, et al. Neutralization of tumor acidity improves antitumor responses to immunotherapy. Cancer Res. 2016;76:1381\u201390. https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-1743.","journal-title":"Cancer Res"},{"key":"7_CR38","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nature10491","volume":"478","author":"CA Opitz","year":"2011","unstructured":"Opitz CA, Litzenburger UM, Sahm F, et al. An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor. Nature. 2011;478:197\u2013203. https:\/\/doi.org\/10.1038\/nature10491.","journal-title":"Nature"},{"key":"7_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17750-z","volume":"11","author":"LF Campesato","year":"2020","unstructured":"Campesato LF, Budhu S, Tchaicha J, et al. Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine. Nat Commun. 2020;11:4011. https:\/\/doi.org\/10.1038\/s41467-020-17750-z.","journal-title":"Nat Commun"},{"key":"7_CR40","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.cell.2016.09.031","volume":"167","author":"R Geiger","year":"2016","unstructured":"Geiger R, Rieckmann JC, Wolf T, et al. L-arginine modulates T cell metabolism and enhances survival and anti-tumor activity. Cell. 2016;167:829\u2013842.e13. https:\/\/doi.org\/10.1016\/j.cell.2016.09.031.","journal-title":"Cell"},{"key":"7_CR41","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.80721","volume":"12","author":"RE Menjivar","year":"2023","unstructured":"Menjivar RE, Nwosu ZC, Du W, et al. Arginase 1 is a key driver of immune suppression in pancreatic cancer. eLife. 2023;12:e80721. https:\/\/doi.org\/10.7554\/eLife.80721.","journal-title":"eLife"},{"key":"7_CR42","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1084\/jem.20131916","volume":"211","author":"MZ Noman","year":"2014","unstructured":"Noman MZ, Desantis G, Janji B, et al. PD-L1 is a novel direct target of HIF-1\u03b1, and its blockade under hypoxia enhanced MDSC-mediated T cell activation. J Exp Med. 2014;211:781\u201390. https:\/\/doi.org\/10.1084\/jem.20131916.","journal-title":"J Exp Med"},{"key":"7_CR43","doi-asserted-by":"publisher","unstructured":"Bailey CM, Liu Y, Liu M, et al. Targeting HIF-1\u03b1 abrogates PD-L1\u2013mediated immune evasion in tumor microenvironment but promotes tolerance in normal tissues. J Clin Invest. 2022;132 https:\/\/doi.org\/10.1172\/JCI150846.","DOI":"10.1172\/JCI150846"},{"key":"7_CR44","doi-asserted-by":"publisher","first-page":"13132","DOI":"10.1073\/pnas.0605251103","volume":"103","author":"A Ohta","year":"2006","unstructured":"Ohta A, Gorelik E, Prasad SJ, et al. A2A adenosine receptor protects tumors from antitumor T cells. Proc Natl Acad Sci. 2006;103:13132\u20137. https:\/\/doi.org\/10.1073\/pnas.0605251103.","journal-title":"Proc Natl Acad Sci"},{"key":"7_CR45","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/imr.12528","volume":"276","author":"B Allard","year":"2017","unstructured":"Allard B, Longhi MS, Robson SC, Stagg J. The ectonucleotidases CD39 and CD73: novel checkpoint inhibitor targets. Immunol Rev. 2017;276:121\u201344. https:\/\/doi.org\/10.1111\/imr.12528.","journal-title":"Immunol Rev"},{"key":"7_CR46","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1126\/science.aav2588","volume":"366","author":"RD Leone","year":"2019","unstructured":"Leone RD, Zhao L, Englert JM, et al. Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion. Science. 2019;366:1013\u201321. https:\/\/doi.org\/10.1126\/science.aav2588.","journal-title":"Science"},{"key":"7_CR47","doi-asserted-by":"publisher","first-page":"3865","DOI":"10.1172\/JCI131859","volume":"130","author":"M-H Oh","year":"2020","unstructured":"Oh M-H, Sun I-H, Zhao L, et al. Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cells. J Clin Invest. 2020;130:3865\u201384. https:\/\/doi.org\/10.1172\/JCI131859.","journal-title":"J Clin Invest"},{"key":"7_CR48","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.cmet.2016.12.011","volume":"25","author":"EH Ma","year":"2017","unstructured":"Ma EH, Bantug G, Griss T, et al. Serine is an essential metabolite for effector T cell expansion. Cell Metab. 2017;25:345\u201357. https:\/\/doi.org\/10.1016\/j.cmet.2016.12.011.","journal-title":"Cell Metab"},{"key":"7_CR49","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/j.immuni.2021.05.003","volume":"54","author":"S Xu","year":"2021","unstructured":"Xu S, Chaudhary O, Rodr\u00edguez-Morales P, et al. Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8+ T cells in tumors. Immunity. 2021;54:1561\u20131577.e7. https:\/\/doi.org\/10.1016\/j.immuni.2021.05.003.","journal-title":"Immunity"},{"key":"7_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7692","volume":"6","author":"N Patsoukis","year":"2015","unstructured":"Patsoukis N, Bardhan K, Chatterjee P, et al. PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation. Nat Commun. 2015;6:6692. https:\/\/doi.org\/10.1038\/ncomms7692.","journal-title":"Nat Commun"},{"key":"7_CR51","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s44276-025-00146-1","volume":"3","author":"A Hegoburu","year":"2025","unstructured":"Hegoburu A, Amer M, Frizelle F, Purcell R. B cells and tertiary lymphoid structures in cancer therapy response. BJC Rep. 2025;3:40. https:\/\/doi.org\/10.1038\/s44276-025-00146-1.","journal-title":"BJC Rep"},{"key":"7_CR52","doi-asserted-by":"publisher","unstructured":"Liu C, Cao J. The pivotal role of tertiary lymphoid structures in the tumor immune microenvironment. Front Oncol. 2025;15 https:\/\/doi.org\/10.3389\/fonc.2025.1616904.","DOI":"10.3389\/fonc.2025.1616904"},{"key":"7_CR53","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1002\/ijc.35229","volume":"156","author":"S Muraoka","year":"2025","unstructured":"Muraoka S, Baba T, Akazawa T, et al. Tumor-derived lactic acid promotes acetylation of histone H3K27 and differentiation of IL-10-producing regulatory B cells through direct and indirect signaling pathways. Int J Cancer. 2025;156:840\u201352. https:\/\/doi.org\/10.1002\/ijc.35229.","journal-title":"Int J Cancer"},{"key":"7_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-02082-x","volume":"10","author":"J Chen","year":"2025","unstructured":"Chen J, Huang Z, Chen Y, et al. Lactate and lactylation in cancer. Signal Transduct Target Ther. 2025;10:38. https:\/\/doi.org\/10.1038\/s41392-024-02082-x.","journal-title":"Signal Transduct Target Ther"},{"key":"7_CR55","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1007\/s00262-020-02535-6","volume":"69","author":"SS Jeske","year":"2020","unstructured":"Jeske SS, Brand M, Ziebart A, et al. Adenosine-producing regulatory B cells in head and neck cancer. Cancer Immunol Immunother. 2020;69:1205\u201316. https:\/\/doi.org\/10.1007\/s00262-020-02535-6.","journal-title":"Cancer Immunol Immunother"},{"key":"7_CR56","doi-asserted-by":"publisher","unstructured":"Tousif S, Wang Y, Jackson J, et al. Indoleamine 2, 3-dioxygenase promotes aryl hydrocarbon receptor-dependent differentiation of regulatory B cells in lung cancer. Front Immunol. 2021;12 https:\/\/doi.org\/10.3389\/fimmu.2021.747780.","DOI":"10.3389\/fimmu.2021.747780"},{"key":"7_CR57","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1186\/s12967-022-03554-w","volume":"20","author":"EE Abd El-Fattah","year":"2022","unstructured":"Abd El-Fattah EE. IDO\/kynurenine pathway in cancer: possible therapeutic approaches. J Transl Med. 2022;20:347. https:\/\/doi.org\/10.1186\/s12967-022-03554-w.","journal-title":"J Transl Med"},{"key":"7_CR58","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/s41590-024-01798-w","volume":"25","author":"HF Bradford","year":"2024","unstructured":"Bradford HF, McDonnell TCR, Stewart A, et al. Thioredoxin is a metabolic rheostat controlling regulatory B cells. Nat Immunol. 2024;25:873\u201385. https:\/\/doi.org\/10.1038\/s41590-024-01798-w.","journal-title":"Nat Immunol"},{"key":"7_CR59","doi-asserted-by":"publisher","first-page":"832","DOI":"10.62347\/ZIAX8828","volume":"14","author":"S-L Lian","year":"2024","unstructured":"Lian S-L, Lu Y-T, Lu Y-J, et al. Tumor-associated macrophages promoting PD-L1 expression in infiltrating B cells through the CXCL12\/CXCR4 axis in human hepatocellular carcinoma. Am J Cancer Res. 2024;14:832\u201353. https:\/\/doi.org\/10.62347\/ZIAX8828.","journal-title":"Am J Cancer Res"},{"key":"7_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2025.104844","volume":"214","author":"H Zhang","year":"2025","unstructured":"Zhang H, Liu S, Fu S, et al. Novel insight into the Warburg effect: sweet temptation. Crit Rev Oncol Hematol. 2025;214:104844. https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104844.","journal-title":"Crit Rev Oncol Hematol"},{"key":"7_CR61","doi-asserted-by":"publisher","first-page":"388","DOI":"10.5483\/BMBRep.2024-0031","volume":"57","author":"SA Lim","year":"2024","unstructured":"Lim SA. Metabolic reprogramming of the tumor microenvironment to enhance immunotherapy. BMB Rep. 2024;57:388\u201399. https:\/\/doi.org\/10.5483\/BMBRep.2024-0031.","journal-title":"BMB Rep"},{"key":"7_CR62","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02278","volume":"10","author":"I Terr\u00e9n","year":"2019","unstructured":"Terr\u00e9n I, Orrantia A, Vitall\u00e9 J, et al. NK cell metabolism and tumor microenvironment. Front Immunol. 2019;10:2278. https:\/\/doi.org\/10.3389\/fimmu.2019.02278.","journal-title":"Front Immunol"},{"key":"7_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22115703","volume":"22","author":"V Infantino","year":"2021","unstructured":"Infantino V, Santarsiero A, Convertini P, et al. Cancer cell metabolism in hypoxia: role of HIF-1 as key regulator and therapeutic target. Int J Mol Sci. 2021;22:5703. https:\/\/doi.org\/10.3390\/ijms22115703.","journal-title":"Int J Mol Sci"},{"key":"7_CR64","doi-asserted-by":"publisher","first-page":"9521","DOI":"10.3390\/ijms24119521","volume":"24","author":"F Portale","year":"2023","unstructured":"Portale F, Di Mitri D. NK cells in cancer: mechanisms of dysfunction and therapeutic potential. Int J Mol Sci. 2023;24:9521. https:\/\/doi.org\/10.3390\/ijms24119521.","journal-title":"Int J Mol Sci"},{"key":"7_CR65","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.800630","volume":"12","author":"X Song","year":"2021","unstructured":"Song X, Si Q, Qi R, et al. Indoleamine 2,3-dioxygenase 1: a promising therapeutic target in malignant tumor. Front Immunol. 2021;12:800630. https:\/\/doi.org\/10.3389\/fimmu.2021.800630.","journal-title":"Front Immunol"},{"key":"7_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.plipres.2020.101055","volume":"80","author":"KC Corn","year":"2020","unstructured":"Corn KC, Windham MA, Rafat M. Lipids in the tumor microenvironment: from cancer progression to treatment. Prog Lipid Res. 2020;80:101055. https:\/\/doi.org\/10.1016\/j.plipres.2020.101055.","journal-title":"Prog Lipid Res"},{"key":"7_CR67","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.20892\/j.issn.2095-3941.2022.0381","volume":"19","author":"J Wi\u00dffeld","year":"2022","unstructured":"Wi\u00dffeld J, Werner A, Yan X, et al. Metabolic regulation of immune responses to cancer. Cancer Biol Med. 2022;19:1528\u201342. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2022.0381.","journal-title":"Cancer Biol Med"},{"key":"7_CR68","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1563303","volume":"16","author":"X-Y Gu","year":"2025","unstructured":"Gu X-Y, Yang J-L, Lai R, et al. Impact of lactate on immune cell function in the tumor microenvironment: mechanisms and therapeutic perspectives. Front Immunol. 2025;16:1563303. https:\/\/doi.org\/10.3389\/fimmu.2025.1563303.","journal-title":"Front Immunol"},{"key":"7_CR69","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.924775","volume":"13","author":"I Garc\u00e9s-L\u00e1zaro","year":"2022","unstructured":"Garc\u00e9s-L\u00e1zaro I, Kotzur R, Cerwenka A, Mandelboim O. NK cells under hypoxia: the two faces of vascularization in tumor and pregnancy. Front Immunol. 2022;13:924775. https:\/\/doi.org\/10.3389\/fimmu.2022.924775.","journal-title":"Front Immunol"},{"key":"7_CR70","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.3389\/fimmu.2019.03038","volume":"10","author":"O Melaiu","year":"2020","unstructured":"Melaiu O, Lucarini V, Cifaldi L, Fruci D. Influence of the tumor microenvironment on NK cell function in solid tumors. Front Immunol. 2020;10:3038. https:\/\/doi.org\/10.3389\/fimmu.2019.03038.","journal-title":"Front Immunol"},{"key":"7_CR71","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.cmet.2021.03.023","volume":"33","author":"SM Poznanski","year":"2021","unstructured":"Poznanski SM, Singh K, Ritchie TM, et al. Metabolic flexibility determines human NK cell functional fate in the tumor microenvironment. Cell Metab. 2021;33:1205\u20131220.e5. https:\/\/doi.org\/10.1016\/j.cmet.2021.03.023.","journal-title":"Cell Metab"},{"key":"7_CR72","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.imlet.2017.08.010","volume":"190","author":"KS Schluns","year":"2017","unstructured":"Robinson TO, Schluns KS. The potential and promise of IL-15 in immuno-oncogenic therapies. Immunol Lett. 2017;190:159\u201368. https:\/\/doi.org\/10.1016\/j.imlet.2017.08.010.","journal-title":"Immunol Lett"},{"key":"7_CR73","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.613492","volume":"12","author":"X Peng","year":"2021","unstructured":"Peng X, He Y, Huang J, et al. Metabolism of dendritic cells in tumor microenvironment: for immunotherapy. Front Immunol. 2021;12:613492. https:\/\/doi.org\/10.3389\/fimmu.2021.613492.","journal-title":"Front Immunol"},{"key":"7_CR74","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01316-8","volume":"20","author":"L Xia","year":"2021","unstructured":"Xia L, Oyang L, Lin J, et al. The cancer metabolic reprogramming and immune response. Mol Cancer. 2021;20:28. https:\/\/doi.org\/10.1186\/s12943-021-01316-8.","journal-title":"Mol Cancer"},{"key":"7_CR75","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-024-00646-1","volume":"12","author":"H Zhang","year":"2024","unstructured":"Zhang H, Li S, Wang D, et al. Metabolic reprogramming and immune evasion: the interplay in the tumor microenvironment. Biomark Res. 2024;12:96. https:\/\/doi.org\/10.1186\/s40364-024-00646-1.","journal-title":"Biomark Res"},{"key":"7_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15620","volume":"8","author":"SJ Lawless","year":"2017","unstructured":"Lawless SJ, Kedia-Mehta N, Walls JF, et al. Glucose represses dendritic cell-induced T cell responses. Nat Commun. 2017;8:15620. https:\/\/doi.org\/10.1038\/ncomms15620.","journal-title":"Nat Commun"},{"key":"7_CR77","doi-asserted-by":"publisher","first-page":"606","DOI":"10.3390\/ph14070606","volume":"14","author":"A Mor","year":"2021","unstructured":"Mor A, Tankiewicz-Kwedlo A, Pawlak D. Kynurenines as a novel target for the treatment of malignancies. Pharmaceuticals. 2021;14:606. https:\/\/doi.org\/10.3390\/ph14070606.","journal-title":"Pharmaceuticals"},{"key":"7_CR78","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.it.2020.09.007","volume":"41","author":"E Proietti","year":"2020","unstructured":"Proietti E, Rossini S, Grohmann U, Mondanelli G. Polyamines and kynurenines at the intersection of immune modulation. Trends Immunol. 2020;41:1037\u201350. https:\/\/doi.org\/10.1016\/j.it.2020.09.007.","journal-title":"Trends Immunol"},{"key":"7_CR79","doi-asserted-by":"publisher","first-page":"3247","DOI":"10.4049\/jimmunol.1900765","volume":"203","author":"M Kayhan","year":"2019","unstructured":"Kayhan M, Koyas A, Akdemir I, et al. adenosine receptor signaling targets both PKA and Epac pathways to polarize dendritic cells to a suppressive phenotype. J Immunol (Baltim Md 1950). 2019;203:3247\u201355. https:\/\/doi.org\/10.4049\/jimmunol.1900765.","journal-title":"J Immunol (Baltim Md 1950)"},{"key":"7_CR80","doi-asserted-by":"publisher","unstructured":"Da M, Chen L, Enk A, et al. The multifaceted actions of CD73 during development and suppressive actions of regulatory T cells. Front Immunol. 2022;13 https:\/\/doi.org\/10.3389\/fimmu.2022.914799.","DOI":"10.3389\/fimmu.2022.914799"},{"key":"7_CR81","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.984560","volume":"12","author":"D Wang","year":"2022","unstructured":"Wang D, Ye Q, Gu H, Chen Z. The role of lipid metabolism in tumor immune microenvironment and potential therapeutic strategies. Front Oncol. 2022;12:984560. https:\/\/doi.org\/10.3389\/fonc.2022.984560.","journal-title":"Front Oncol"},{"key":"7_CR82","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.828875","volume":"13","author":"R Abou Khouzam","year":"2022","unstructured":"Abou Khouzam R, Zaarour RF, Brodaczewska K, et al. The effect of hypoxia and hypoxia-associated pathways in the regulation of antitumor response: friends or foes? Front Immunol. 2022;13:828875. https:\/\/doi.org\/10.3389\/fimmu.2022.828875.","journal-title":"Front Immunol"},{"key":"7_CR83","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0244366","volume":"15","author":"CW Tran","year":"2020","unstructured":"Tran CW, Gold MJ, Garcia-Batres C, et al. Hypoxia-inducible factor 1 alpha limits dendritic cell stimulation of CD8 T cell immunity. PLoS One. 2020;15:e0244366. https:\/\/doi.org\/10.1371\/journal.pone.0244366.","journal-title":"PLoS One"},{"key":"7_CR84","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.it.2019.06.004","volume":"40","author":"P Giovanelli","year":"2019","unstructured":"Giovanelli P, Sandoval TA, Cubillos-Ruiz JR. Dendritic cell metabolism and function in tumors. Trends Immunol. 2019;40:699\u2013718. https:\/\/doi.org\/10.1016\/j.it.2019.06.004.","journal-title":"Trends Immunol"},{"key":"7_CR85","doi-asserted-by":"publisher","DOI":"10.1172\/JCI177606","volume":"134","author":"S Verma","year":"2024","unstructured":"Verma S, Budhu S, Serganova I, et al. Pharmacologic LDH inhibition redirects intratumoral glucose uptake and improves antitumor immunity in solid tumor models. J Clin Invest. 2024;134:e177606. https:\/\/doi.org\/10.1172\/JCI177606.","journal-title":"J Clin Invest"},{"key":"7_CR86","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-021-01080-8","volume":"14","author":"K Tang","year":"2021","unstructured":"Tang K, Wu Y-H, Song Y, Yu B. Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors in clinical trials for cancer immunotherapy. J Hematol Oncol. 2021;14:68. https:\/\/doi.org\/10.1186\/s13045-021-01080-8.","journal-title":"J Hematol Oncol"},{"key":"7_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107848","volume":"32","author":"L Guerra","year":"2020","unstructured":"Guerra L, Bonetti L, Brenner D. Metabolic modulation of immunity: a new concept in cancer immunotherapy. Cell Rep. 2020;32:107848. https:\/\/doi.org\/10.1016\/j.celrep.2020.107848.","journal-title":"Cell Rep"},{"key":"7_CR88","doi-asserted-by":"publisher","first-page":"598","DOI":"10.20892\/j.issn.2095-3941.2025.0023","volume":"22","author":"Z Wang","year":"2025","unstructured":"Wang Z, Hu H, Bao Y, et al. Neutrophils in cancer: from immune defense to tumor promotion. Cancer Biol Med. 2025;22:598\u2013617. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2025.0023.","journal-title":"Cancer Biol Med"},{"key":"7_CR89","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2025.1584987","volume":"13","author":"J Lin","year":"2025","unstructured":"Lin J, He X-L, Zhang W-W, Mo C-F. Metabolic reprogramming of tumor-associated neutrophils in tumor treatment and therapeutic resistance. Front Cell Dev Biol. 2025;13:1584987. https:\/\/doi.org\/10.3389\/fcell.2025.1584987.","journal-title":"Front Cell Dev Biol"},{"key":"7_CR90","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s13045-021-01187-y","volume":"14","author":"S Xiong","year":"2021","unstructured":"Xiong S, Dong L, Cheng L. Neutrophils in cancer carcinogenesis and metastasis. J Hematol Oncol. 2021;14:173. https:\/\/doi.org\/10.1186\/s13045-021-01187-y.","journal-title":"J Hematol Oncol"},{"key":"7_CR91","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41586-019-1118-2","volume":"569","author":"F Veglia","year":"2019","unstructured":"Veglia F, Tyurin VA, Blasi M, et al. Fatty acid transporter 2 reprograms neutrophils in cancer. Nature. 2019;569:73\u20138. https:\/\/doi.org\/10.1038\/s41586-019-1118-2.","journal-title":"Nature"},{"key":"7_CR92","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-025-00784-0","volume":"13","author":"Y Yang","year":"2025","unstructured":"Yang Y, Zhu L, Xu Y, et al. The progress and prospects of targeting the adenosine pathway in cancer immunotherapy. Biomark Res. 2025;13:75. https:\/\/doi.org\/10.1186\/s40364-025-00784-0.","journal-title":"Biomark Res"},{"key":"7_CR93","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-023-02634-z","volume":"42","author":"S Tan","year":"2023","unstructured":"Tan S, Yang Y, Yang W, et al. Exosomal cargos-mediated metabolic reprogramming in tumor microenvironment. J Exp Clin Cancer Res. 2023;42:59. https:\/\/doi.org\/10.1186\/s13046-023-02634-z.","journal-title":"J Exp Clin Cancer Res"},{"key":"7_CR94","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-025-01731-0","volume":"18","author":"Y Feng","year":"2025","unstructured":"Feng Y, Liu G, Li H, Cheng L. Target neutrophil heterogeneity and plasticity in cancer. J Hematol OncolJ Hematol Oncol. 2025;18:79. https:\/\/doi.org\/10.1186\/s13045-025-01731-0.","journal-title":"J Hematol OncolJ Hematol Oncol"},{"key":"7_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2025.107811","volume":"217","author":"M Ma","year":"2025","unstructured":"Ma M, Hu R, Huang Q, et al. Decoding the metabolic-immune Axis: neutrophil glycolysis-driven tumor niche remodeling and its therapeutic exploitation. Pharmacol Res. 2025;217:107811. https:\/\/doi.org\/10.1016\/j.phrs.2025.107811.","journal-title":"Pharmacol Res"},{"key":"7_CR96","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1152\/physrev.00037.2016","volume":"98","author":"RW Caldwell","year":"2018","unstructured":"Caldwell RW, Rodriguez PC, Toque HA, et al. Arginase: a multifaceted enzyme important in health and disease. Physiol Rev. 2018;98:641\u201365. https:\/\/doi.org\/10.1152\/physrev.00037.2016.","journal-title":"Physiol Rev"},{"key":"7_CR97","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232415827","volume":"23","author":"K Sounbuli","year":"2022","unstructured":"Sounbuli K, Mironova N, Alekseeva L. Diverse neutrophil functions in cancer and promising neutrophil-based cancer therapies. Int J Mol Sci. 2022;23:15827. https:\/\/doi.org\/10.3390\/ijms232415827.","journal-title":"Int J Mol Sci"},{"key":"7_CR98","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.trecan.2019.10.007","volume":"5","author":"K Mehla","year":"2019","unstructured":"Mehla K, Singh PK. Metabolic regulation of macrophage polarization in cancer. Trends Cancer. 2019;5:822\u201334. https:\/\/doi.org\/10.1016\/j.trecan.2019.10.007.","journal-title":"Trends Cancer"},{"key":"7_CR99","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01452-1","volume":"8","author":"S Chen","year":"2023","unstructured":"Chen S, Saeed AFUH, Liu Q, et al. Macrophages in immunoregulation and therapeutics. Signal Transduct Target Ther. 2023;8:207. https:\/\/doi.org\/10.1038\/s41392-023-01452-1.","journal-title":"Signal Transduct Target Ther"},{"key":"7_CR100","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01645-2","volume":"21","author":"R Bai","year":"2022","unstructured":"Bai R, Li Y, Jian L, et al. The hypoxia-driven crosstalk between tumor and tumor-associated macrophages: mechanisms and clinical treatment strategies. Mol Cancer. 2022;21:177. https:\/\/doi.org\/10.1186\/s12943-022-01645-2.","journal-title":"Mol Cancer"},{"key":"7_CR101","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-019-1027-0","volume":"38","author":"W Ren","year":"2019","unstructured":"Ren W, Hou J, Yang C, et al. Extracellular vesicles secreted by hypoxia pre-challenged mesenchymal stem cells promote non-small cell lung cancer cell growth and mobility as well as macrophage M2 polarization via miR-21-5p delivery. J Exp Clin Cancer Res. 2019;38:62. https:\/\/doi.org\/10.1186\/s13046-019-1027-0.","journal-title":"J Exp Clin Cancer Res"},{"key":"7_CR102","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13045-025-01688-0","volume":"18","author":"H Jia","year":"2025","unstructured":"Jia H, Chen X, Zhang L, Chen M. Cancer associated fibroblasts in cancer development and therapy. J Hematol Oncol. 2025;18:36. https:\/\/doi.org\/10.1186\/s13045-025-01688-0.","journal-title":"J Hematol Oncol"},{"key":"7_CR103","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1007\/s10555-024-10186-7","volume":"43","author":"T Guo","year":"2024","unstructured":"Guo T, Xu J. Cancer-associated fibroblasts: a versatile mediator in tumor progression, metastasis, and targeted therapy. Cancer Metastasis Rev. 2024;43:1095\u2013116. https:\/\/doi.org\/10.1007\/s10555-024-10186-7.","journal-title":"Cancer Metastasis Rev"},{"key":"7_CR104","doi-asserted-by":"publisher","first-page":"8322","DOI":"10.7150\/thno.62378","volume":"11","author":"Z Li","year":"2021","unstructured":"Li Z, Sun C, Qin Z. Metabolic reprogramming of cancer-associated fibroblasts and its effect on cancer cell reprogramming. Theranostics. 2021;11:8322\u201336. https:\/\/doi.org\/10.7150\/thno.62378.","journal-title":"Theranostics"},{"key":"7_CR105","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2025.156151","volume":"273","author":"D De Leon-Oliva","year":"2025","unstructured":"De Leon-Oliva D, Gonz\u00e1lez-Prieto P, De Castro-Martinez P, et al. Revisiting the biological role of the Warburg effect: evolving perspectives on cancer metabolism. Pathol \u2013 Res Pract. 2025;273:156151. https:\/\/doi.org\/10.1016\/j.prp.2025.156151.","journal-title":"Pathol \u2013 Res Pract"},{"key":"7_CR106","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.bbcan.2016.09.001","volume":"1866","author":"C Liang","year":"2016","unstructured":"Liang C, Qin Y, Zhang B, et al. Metabolic plasticity in heterogeneous pancreatic ductal adenocarcinoma. Biochim Biophys Acta BBA \u2013 Rev Cancer. 2016;1866:177\u201388. https:\/\/doi.org\/10.1016\/j.bbcan.2016.09.001.","journal-title":"Biochim Biophys Acta BBA \u2013 Rev Cancer"},{"key":"7_CR107","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-021-02121-5","volume":"21","author":"X Li","year":"2021","unstructured":"Li X, Zhu H, Sun W, et al. Role of glutamine and its metabolite ammonia in crosstalk of cancer-associated fibroblasts and cancer cells. Cancer Cell Int. 2021;21:479. https:\/\/doi.org\/10.1186\/s12935-021-02121-5.","journal-title":"Cancer Cell Int"},{"key":"7_CR108","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.112840","volume":"149","author":"F Niu","year":"2022","unstructured":"Niu F, Yu Y, Li Z, et al. Arginase: An emerging and promising therapeutic target for cancer treatment. Biomed Pharmacother. 2022;149:112840. https:\/\/doi.org\/10.1016\/j.biopha.2022.112840.","journal-title":"Biomed Pharmacother"},{"key":"7_CR109","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-023-00665-y","volume":"29","author":"Z Peng","year":"2023","unstructured":"Peng Z, Tong Z, Ren Z, et al. Cancer-associated fibroblasts and its derived exosomes: a new perspective for reshaping the tumor microenvironment. Mol Med. 2023;29:66. https:\/\/doi.org\/10.1186\/s10020-023-00665-y.","journal-title":"Mol Med"},{"key":"7_CR110","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2025.1568865","volume":"12","author":"MR Brogna","year":"2025","unstructured":"Brogna MR, Varone V, DelSesto M, Ferrara G. The role of CAFs in therapeutic resistance in triple negative breast cancer: an emerging challenge. Front Mol Biosci. 2025;12:1568865. https:\/\/doi.org\/10.3389\/fmolb.2025.1568865.","journal-title":"Front Mol Biosci"},{"key":"7_CR111","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.7150\/ijbs.68484","volume":"18","author":"S Peng","year":"2022","unstructured":"Peng S, Li Y, Huang M, et al. Metabolomics reveals that CAF-derived lipids promote colorectal cancer peritoneal metastasis by enhancing membrane fluidity. Int J Biol Sci. 2022;18:1912\u201332. https:\/\/doi.org\/10.7150\/ijbs.68484.","journal-title":"Int J Biol Sci"},{"key":"7_CR112","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1084\/jem.20100587","volume":"207","author":"CA Corzo","year":"2010","unstructured":"Corzo CA, Condamine T, Lu L, et al. HIF-1\u03b1 regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment. J Exp Med. 2010;207:2439\u201353. https:\/\/doi.org\/10.1084\/jem.20100587.","journal-title":"J Exp Med"},{"key":"7_CR113","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.molmet.2019.07.006","volume":"33","author":"VL Payen","year":"2019","unstructured":"Payen VL, Mina E, Van H\u00e9e VF, et al. Monocarboxylate transporters in cancer. Mol Metab. 2019;33:48\u201366. https:\/\/doi.org\/10.1016\/j.molmet.2019.07.006.","journal-title":"Mol Metab"},{"key":"7_CR114","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.drudis.2016.12.003","volume":"22","author":"MJ Lukey","year":"2017","unstructured":"Lukey MJ, Katt WP, Cerione RA. Targeting amino acid metabolism for cancer therapy. Drug Discov Today. 2017;22:796\u2013804. https:\/\/doi.org\/10.1016\/j.drudis.2016.12.003.","journal-title":"Drug Discov Today"},{"key":"7_CR115","doi-asserted-by":"publisher","first-page":"3935","DOI":"10.3390\/molecules25173935","volume":"25","author":"CW Fhu","year":"2020","unstructured":"Fhu CW, Ali A. Fatty acid synthase: An emerging target in cancer. Molecules. 2020;25:3935. https:\/\/doi.org\/10.3390\/molecules25173935.","journal-title":"Molecules"},{"key":"7_CR116","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12929-024-01099-2","volume":"32","author":"Z Cao","year":"2025","unstructured":"Cao Z, Quazi S, Arora S, et al. Cancer-associated fibroblasts as therapeutic targets for cancer: advances, challenges, and future prospects. J Biomed Sci. 2025;32:7. https:\/\/doi.org\/10.1186\/s12929-024-01099-2.","journal-title":"J Biomed Sci"},{"key":"7_CR117","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231911052","volume":"23","author":"M Garc\u00eda-Caballero","year":"2022","unstructured":"Garc\u00eda-Caballero M, Sokol L, Cuypers A, Carmeliet P. Metabolic reprogramming in tumor endothelial cells. Int J Mol Sci. 2022;23:11052. https:\/\/doi.org\/10.3390\/ijms231911052.","journal-title":"Int J Mol Sci"},{"key":"7_CR118","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1161\/ATVBAHA.113.303041","volume":"34","author":"Y Xu","year":"2014","unstructured":"Xu Y, An X, Guo X, et al. Endothelial 6-phosphofructo-2-kinase (PFKFB3) plays a critical role in angiogenesis. Arterioscler Thromb Vasc Biol. 2014;34:1231\u20139. https:\/\/doi.org\/10.1161\/ATVBAHA.113.303041.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"7_CR119","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41388-024-03228-5","volume":"44","author":"K Kane","year":"2025","unstructured":"Kane K, Edwards D, Chen J. The influence of endothelial metabolic reprogramming on the tumor microenvironment. Oncogene. 2025;44:51\u201363. https:\/\/doi.org\/10.1038\/s41388-024-03228-5.","journal-title":"Oncogene"},{"key":"7_CR120","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0033418","volume":"7","author":"P Sonveaux","year":"2012","unstructured":"Sonveaux P, Copetti T, Saedeleer CJD, et al. Targeting the lactate transporter MCT1 in endothelial cells inhibits lactate-induced HIF-1 activation and tumor angiogenesis. PLoS One. 2012;7:e33418. https:\/\/doi.org\/10.1371\/journal.pone.0033418.","journal-title":"PLoS One"},{"key":"7_CR121","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.15252\/embj.201695518","volume":"36","author":"H Huang","year":"2017","unstructured":"Huang H, Vandekeere S, Kalucka J, et al. Role of glutamine and interlinked asparagine metabolism in vessel formation. EMBO J. 2017;36:2334\u201352. https:\/\/doi.org\/10.15252\/embj.201695518.","journal-title":"EMBO J"},{"key":"7_CR122","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.3390\/genes13122301","volume":"13","author":"B Liu","year":"2022","unstructured":"Liu B, Dai Z. Fatty acid metabolism in endothelial cell. Genes. 2022;13:2301. https:\/\/doi.org\/10.3390\/genes13122301.","journal-title":"Genes"},{"key":"7_CR123","doi-asserted-by":"publisher","first-page":"24990","DOI":"10.1074\/jbc.M112.340083","volume":"287","author":"A Mukherjee","year":"2012","unstructured":"Mukherjee A, Wu J, Barbour S, Fang X. Lysophosphatidic acid activates Lipogenic pathways and de novo lipid synthesis in ovarian cancer cells. J Biol Chem. 2012;287:24990\u20135000. https:\/\/doi.org\/10.1074\/jbc.M112.340083.","journal-title":"J Biol Chem"},{"key":"7_CR124","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01760-1","volume":"22","author":"X Liu","year":"2024","unstructured":"Liu X, Ren B, Ren J, et al. The significant role of amino acid metabolic reprogramming in cancer. Cell Commun Signal. 2024;22:380. https:\/\/doi.org\/10.1186\/s12964-024-01760-1.","journal-title":"Cell Commun Signal"},{"key":"7_CR125","doi-asserted-by":"publisher","first-page":"dmm033332","DOI":"10.1242\/dmm.033332","volume":"11","author":"R Keshet","year":"2018","unstructured":"Keshet R, Erez A. Arginine and the metabolic regulation of nitric oxide synthesis in cancer. Dis Model Mech. 2018;11:dmm033332. https:\/\/doi.org\/10.1242\/dmm.033332.","journal-title":"Dis Model Mech"},{"key":"7_CR126","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-02018-6","volume":"23","author":"D Nan","year":"2025","unstructured":"Nan D, Yao W, Huang L, et al. Glutamine and cancer: metabolism, immune microenvironment, and therapeutic targets. Cell Commun Signal. 2025;23:45. https:\/\/doi.org\/10.1186\/s12964-024-02018-6.","journal-title":"Cell Commun Signal"},{"key":"7_CR127","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14112793","volume":"14","author":"R Gouasmi","year":"2022","unstructured":"Gouasmi R, Ferraro-Peyret C, Nancey S, et al. The kynurenine pathway and cancer: why keep it simple when You can make it complicated. Cancer. 2022;14:2793. https:\/\/doi.org\/10.3390\/cancers14112793.","journal-title":"Cancer"},{"key":"7_CR128","doi-asserted-by":"publisher","first-page":"673","DOI":"10.3390\/cells14090673","volume":"14","author":"MZ Bakleh","year":"2025","unstructured":"Bakleh MZ, Al Haj Zen A. The distinct role of HIF-1\u03b1 and HIF-2\u03b1 in hypoxia and angiogenesis. Cells. 2025;14:673. https:\/\/doi.org\/10.3390\/cells14090673.","journal-title":"Cells"},{"key":"7_CR129","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.3390\/cells11091433","volume":"11","author":"ES Fridman","year":"2022","unstructured":"Fridman ES, Ginini L, Gil Z. The role of extracellular vesicles in metabolic reprogramming of the tumor microenvironment. Cells. 2022;11:1433. https:\/\/doi.org\/10.3390\/cells11091433.","journal-title":"Cells"},{"key":"7_CR130","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.3390\/cancers14081865","volume":"14","author":"R Carles-Fontana","year":"2022","unstructured":"Carles-Fontana R, Heaton N, Palma E, Khorsandi SE. Extracellular vesicle-mediated mitochondrial reprogramming in cancer. Cancer. 2022;14:1865. https:\/\/doi.org\/10.3390\/cancers14081865.","journal-title":"Cancer"},{"key":"7_CR131","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.ccell.2016.10.006","volume":"30","author":"AR Cantelmo","year":"2016","unstructured":"Cantelmo AR, Conradi L-C, Brajic A, et al. Inhibition of the glycolytic activator PFKFB3 in endothelium induces tumor vessel normalization, impairs metastasis, and improves chemotherapy. Cancer Cell. 2016;30:968\u201385. https:\/\/doi.org\/10.1016\/j.ccell.2016.10.006.","journal-title":"Cancer Cell"},{"key":"7_CR132","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01332-8","volume":"8","author":"Z Chen","year":"2023","unstructured":"Chen Z, Han F, Du Y, et al. Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions. Signal Transduct Target Ther. 2023;8:70. https:\/\/doi.org\/10.1038\/s41392-023-01332-8.","journal-title":"Signal Transduct Target Ther"},{"key":"7_CR133","doi-asserted-by":"publisher","first-page":"3761","DOI":"10.1158\/0008-5472.CAN-18-0040","volume":"78","author":"W-H Yang","year":"2018","unstructured":"Yang W-H, Cha J-H, Xia W, et al. Juxtacrine signaling inhibits antitumor immunity by upregulating PD-L1 expression. Cancer Res. 2018;78:3761\u20138.","journal-title":"Cancer Res"},{"key":"7_CR134","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3390\/cancers17010155","volume":"17","author":"R Clay","year":"2025","unstructured":"Clay R, Li K, Jin L. Metabolic signaling in the tumor microenvironment. Cancer. 2025;17:155.","journal-title":"Cancer"},{"key":"7_CR135","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-023-01439-z","volume":"16","author":"X Li","year":"2023","unstructured":"Li X, Yan X, Wang Y, et al. The notch signaling pathway: a potential target for cancer immunotherapy. J Hematol Oncol. 2023;16:45. https:\/\/doi.org\/10.1186\/s13045-023-01439-z.","journal-title":"J Hematol Oncol"},{"key":"7_CR136","doi-asserted-by":"publisher","first-page":"18814","DOI":"10.1073\/pnas.1104943108","volume":"108","author":"SK-J Landor","year":"2011","unstructured":"Landor SK-J, Mutvei AP, Mamaeva V, et al. Hypo- and hyperactivated Notch signaling induce a glycolytic switch through distinct mechanisms. Proc Natl Acad Sci. 2011;108:18814\u20139. https:\/\/doi.org\/10.1073\/pnas.1104943108.","journal-title":"Proc Natl Acad Sci"},{"key":"7_CR137","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/s41419-021-04124-6","volume":"12","author":"M Xie","year":"2021","unstructured":"Xie M, Fu X, Jiang K. Notch1\/TAZ axis promotes aerobic glycolysis and immune escape in lung cancer. Cell Death Dis. 2021;12:832.","journal-title":"Cell Death Dis"},{"key":"7_CR138","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.988295","volume":"13","author":"Y Zhu","year":"2022","unstructured":"Zhu Y, Li X, Wang L, et al. Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment. Front Endocrinol. 2022;13:988295.","journal-title":"Front Endocrinol"},{"key":"7_CR139","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/nrc2806","volume":"10","author":"EB Pasquale","year":"2010","unstructured":"Pasquale EB. Eph receptors and ephrins in cancer: bidirectional signalling and beyond. Nat Rev Cancer. 2010;10:165\u201380.","journal-title":"Nat Rev Cancer"},{"key":"7_CR140","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0081445","volume":"8","author":"G Falivelli","year":"2013","unstructured":"Falivelli G, Lisabeth EM, de la Torre ER, et al. Attenuation of eph receptor kinase activation in cancer cells by coexpressed ephrin ligands. PLoS One. 2013;8:e81445.","journal-title":"PLoS One"},{"key":"7_CR141","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1634\/stemcells.18-1-63","volume":"18","author":"PL Jensen","year":"2000","unstructured":"Jensen PL. Eph receptors and ephrins. Stem Cells. 2000;18:63\u20134. https:\/\/doi.org\/10.1634\/stemcells.18-1-63.","journal-title":"Stem Cells"},{"key":"7_CR142","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/978-3-030-47189-7_3","volume-title":"Tumor microenvironment","author":"K Ieguchi","year":"2021","unstructured":"Ieguchi K, Maru Y. Eph\/Ephrin signaling in the tumor microenvironment. In: Birbrair A, editor. Tumor microenvironment. Cham: Springer International Publishing; 2021. p. 45\u201356."},{"key":"7_CR143","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.3390\/ijms20081933","volume":"20","author":"B Sousa","year":"2019","unstructured":"Sousa B, Pereira J, Paredes J. The crosstalk between cell adhesion and cancer metabolism. Int J Mol Sci. 2019;20:1933.","journal-title":"Int J Mol Sci"},{"key":"7_CR144","doi-asserted-by":"publisher","first-page":"446","DOI":"10.18632\/oncotarget.872","volume":"4","author":"K Chu","year":"2013","unstructured":"Chu K, Boley KM, Moraes R, et al. The paradox of E-cadherin: role in response to hypoxia in the tumor microenvironment and regulation of energy metabolism. Oncotarget. 2013;4:446.","journal-title":"Oncotarget"},{"key":"7_CR145","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-022-01009-9","volume":"21","author":"M Zhou","year":"2023","unstructured":"Zhou M, Zheng M, Zhou X, et al. The roles of connexins and gap junctions in the progression of cancer. Cell Commun Signal. 2023;21:8. https:\/\/doi.org\/10.1186\/s12964-022-01009-9.","journal-title":"Cell Commun Signal"},{"key":"7_CR146","doi-asserted-by":"publisher","first-page":"10172","DOI":"10.3390\/ijms231710172","volume":"23","author":"JC Jones","year":"2022","unstructured":"Jones JC, Bodenstine TM. Connexins and glucose metabolism in cancer. Int J Mol Sci. 2022;23:10172.","journal-title":"Int J Mol Sci"},{"key":"7_CR147","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/mc.21863","volume":"52","author":"EC Nakajima","year":"2013","unstructured":"Nakajima EC, Van Houten B. Metabolic symbiosis in cancer: refocusing the Warburg lens. Mol Carcinog. 2013;52:329\u201337. https:\/\/doi.org\/10.1002\/mc.21863.","journal-title":"Mol Carcinog"},{"key":"7_CR148","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20182417","volume":"39","author":"C Li","year":"2019","unstructured":"Li C, Cheung MK, Han S, et al. Mesenchymal stem cells and their mitochondrial transfer: a double-edged sword. Biosci Rep. 2019;39:BSR20182417.","journal-title":"Biosci Rep"},{"key":"7_CR149","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.218","volume":"4","author":"S Nong","year":"2023","unstructured":"Nong S, Han X, Xiang Y, et al. Metabolic reprogramming in cancer: mechanisms and therapeutics. MedComm. 2023;4:e218. https:\/\/doi.org\/10.1002\/mco2.218.","journal-title":"MedComm"},{"key":"7_CR150","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/s41392-023-01442-3","volume":"8","author":"M You","year":"2023","unstructured":"You M, Xie Z, Zhang N, et al. Signaling pathways in cancer metabolism: mechanisms and therapeutic targets. Signal Transduct Target Ther. 2023;8:196.","journal-title":"Signal Transduct Target Ther"},{"key":"7_CR151","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00673","volume":"5","author":"M Platten","year":"2015","unstructured":"Platten M, von Knebel Doeberitz N, Oezen I, et al. Cancer immunotherapy by targeting IDO1\/TDO and their downstream effectors. Front Immunol. 2015;5:673.","journal-title":"Front Immunol"},{"key":"7_CR152","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.1111\/jnc.16015","volume":"168","author":"TW Stone","year":"2024","unstructured":"Stone TW, Williams RO. Tryptophan metabolism as a \u2018reflex\u2019 feature of neuroimmune communication: sensor and effector functions for the indoleamine-2, 3-dioxygenase kynurenine pathway. J Neurochem. 2024;168:3333\u201357. https:\/\/doi.org\/10.1111\/jnc.16015.","journal-title":"J Neurochem"},{"key":"7_CR153","doi-asserted-by":"publisher","first-page":"12150","DOI":"10.1038\/s41598-019-48635-x","volume":"9","author":"S Rad Pour","year":"2019","unstructured":"Rad Pour S, Morikawa H, Kiani NA, et al. Exhaustion of CD4+ T-cells mediated by the kynurenine pathway in melanoma. Sci Rep. 2019;9:12150.","journal-title":"Sci Rep"},{"key":"7_CR154","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1038\/s41467-018-04366-7","volume":"9","author":"LV Sinclair","year":"2018","unstructured":"Sinclair LV, Neyens D, Ramsay G, et al. Single cell analysis of kynurenine and system L amino acid transport in T cells. Nat Commun. 2018;9:1981.","journal-title":"Nat Commun"},{"key":"7_CR155","doi-asserted-by":"publisher","first-page":"3678","DOI":"10.1172\/JCI69600","volume":"123","author":"CT Hensley","year":"2013","unstructured":"Hensley CT, Wasti AT, DeBerardinis RJ. Glutamine and cancer: cell biology, physiology, and clinical opportunities. J Clin Invest. 2013;123:3678\u201384.","journal-title":"J Clin Invest"},{"key":"7_CR156","doi-asserted-by":"publisher","first-page":"109817","DOI":"10.1016\/j.isci.2024.109817","volume":"27","author":"M Kumar","year":"2024","unstructured":"Kumar M, Leekha A, Nandy S, et al. Enzymatic depletion of circulating glutamine is immunosuppressive in cancers. IScience. 2024;27:109817.","journal-title":"IScience"},{"key":"7_CR157","doi-asserted-by":"publisher","first-page":"1435480","DOI":"10.3389\/fonc.2024.1435480","volume":"14","author":"G Pascual","year":"2024","unstructured":"Pascual G, Benitah SA. Lipids in the tumor microenvironment: immune modulation and metastasis. Front Oncol. 2024;14:1435480.","journal-title":"Front Oncol"},{"key":"7_CR158","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1158\/0008-5472.CAN-21-3054","volume":"82","author":"KC Hicks","year":"2022","unstructured":"Hicks KC, Tyurina YY, Kagan VE, Gabrilovich DI. Myeloid cell\u2013derived oxidized lipids and regulation of the tumor microenvironment. Cancer Res. 2022;82:187\u201394.","journal-title":"Cancer Res"},{"key":"7_CR159","first-page":"2710","volume":"8","author":"C Yan","year":"2015","unstructured":"Yan C, Yang F, Zhou C, et al. MCT1 promotes the cisplatin-resistance by antagonizing Fas in epithelial ovarian cancer. Int J Clin Exp Pathol. 2015;8:2710.","journal-title":"Int J Clin Exp Pathol"},{"key":"7_CR160","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3390\/cells11010140","volume":"11","author":"H-C Yoo","year":"2022","unstructured":"Yoo H-C, Han J-M. Amino acid metabolism in cancer drug resistance. Cells. 2022;11:140.","journal-title":"Cells"},{"key":"7_CR161","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1032336","volume":"12","author":"RR Canevarolo","year":"2022","unstructured":"Canevarolo RR, de Melo CPS, Cury NM, et al. Glutathione levels are associated with methotrexate resistance in acute lymphoblastic leukemia cell lines. Front Oncol. 2022;12:1032336.","journal-title":"Front Oncol"},{"key":"7_CR162","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1158\/1535-7163.MCT-20-0430","volume":"20","author":"S Varghese","year":"2021","unstructured":"Varghese S, Pramanik S, Williams LJ, et al. The glutaminase inhibitor CB-839 (telaglenastat) enhances the antimelanoma activity of T-cell\u2013mediated immunotherapies. Mol Cancer Ther. 2021;20:500\u201311.","journal-title":"Mol Cancer Ther"}],"container-title":["Cancer Treatment and Research","Cancer Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-032-21861-2_7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:42:23Z","timestamp":1779064943000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-032-21861-2_7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9783032218605","9783032218612"],"references-count":162,"URL":"https:\/\/doi.org\/10.1007\/978-3-032-21861-2_7","relation":{},"ISSN":["0927-3042","2509-8497"],"issn-type":[{"value":"0927-3042","type":"print"},{"value":"2509-8497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"1 May 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}